(Q40386087)

20 September 2017

title

The carcinoma-specific epithelial glycoprotein-2 promoter controls efficient and selective gene expression in an adenoviral context (English)

1 reference

20 September 2017

1 reference

6

D T Curiel

1 reference

20 September 2017

W M Gommans

1

1 reference

20 September 2017

S J van Eert

2

1 reference

20 September 2017

P M J McLaughlin

3

1 reference

20 September 2017

M C Harmsen

4

1 reference

20 September 2017

M Yamamoto

5

1 reference

20 September 2017

H J Haisma

7

1 reference

20 September 2017

M G Rots

8

1 reference

20 September 2017

publication date

1 February 2006

1 reference

20 September 2017

1 reference

20 September 2017

volume

13

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

150-158

1 reference

Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Blood clearance rates of adenovirus type 5 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Transductional and transcriptional targeting of adenovirus for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Gene therapy: designer promoters for tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Novel prostate-specific promoter derived from PSA and PSMA enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Use of the EGP-2/Ep-CAM promoter for targeted expression of heterologous genes in carcinoma derived cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

The biology of the 17-1A antigen (Ep-CAM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Transcription initiation activity of adenovirus left-end sequence in adenovirus vectors with e1 deleted

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

A simplified system for generating recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Conditional gene targeting for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Transcriptional targeting of tumors with a novel tumor-specific survivin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

Insulation of a conditionally expressed transgene in an adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700882

21 January 2018

Identifiers

DOI

10.1038/SJ.CGT.7700882

1 reference

Dimensions Publication ID

20 September 2017

1032917401

0 references

1 reference